Why the study?
For almost 20 years, data regarding the effect of rhythm control therapy for AF on cardiovascular prognosis compared with rate control therapy has not been conclusive.
Does early initiation of rhythm control reduce adverse cardiovascular events in patients with recent atrial fibrillation?
Does early initiation of rhythm control reduce adverse cardiovascular events in patients with recent atrial fibrillation?
Early rhythm control should be considered in patients with recent atrial fibrillation, regardless of symptoms, to improve cardiovascular outcomes.
Answers are grounded in this paper and cite their sources.
Supports early rhythm control in recent AF; leaves open need for prospective RCTs before practice change.
For almost 20 years, data regarding the effect of rhythm control therapy for atrial fibrillation (AF) on cardiovascular prognosis in comparison with rate control therapy has not been conclusive. The safety of rhythm control and anticoagulation therapy has generally improved. Recently, it was revealed that a rhythm-control strategy reduced the risk of adverse cardiovascular events than usual rate control in patients with recent AF (diagnosed within 1 year). Within 1 year after the AF diagnosis, early initiation of rhythm control led to more favorable cardiovascular outcomes than rate control. Early rhythm control reduced the risks of stroke and heart failure-related admission than rate control. Moreover, rhythm control was associated with lower dementia risk than rate control. Finally, early rhythm control treatment was also effective in patients with asymptomatic AF but less effective in older adults. Therefore, in patients with AF, rhythm control should be considered at earlier stages, regardless of symptom.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: